title: Morin reduces hepatic inflammation-associated lipid accumulation in high fructose-fed rats via inhibiting sphingosine kinase 1/sphingosine 1-phosphate signaling pathway.
abstract: SphK1/S1P signaling pathway is involved in the development of hepatic inflammation and injury. But its role in high fructose-induced NAFLD has not yet been reported. The aim of this study was to elucidate the crucial role of SphK1/S1P signaling pathway in high fructose-induced hepatic inflammation and lipid accumulation in rats. Moreover, the hepatoprotective effects of morin, a flavonoid with anti-inflammatory and anti-hyperlipedimic activities, on these hepatic changes in rats were investigated. High fructose-fed rats were orally treated with morin (30 and 60mg/kg) and pioglitazone (4mg/kg) for 8 weeks, respectively. Fructose feeding induced hyperlipidemia, and activated SphK1/S1P signaling pathway characterized by the elevation of SphK1 activity, S1P production as well as SphK1, S1PR1 and S1PR3 protein levels, which in turn caused NF-κB signaling activation to produce IL-1β, IL-6 and TNF-α and inflammation in the liver of rats. Subsequently, hepatic insulin and leptin signaling impairment and lipid metabolic disorder were observed in this animal model, resulting in liver lipid accumulation. Morin restored high fructose-induced the activation of hepatic SphK1/S1P signaling pathway in rats. Subsequently, the reduced NF-κB signaling activation by morin decreased inflammatory cytokine production, recovered insulin and leptin signaling impairment to reduce lipid accumulation and injury in the rat liver. These effects of morin were confirmed in Buffalo rat liver (BRL3A) cell model stimulated with 5mM fructose. Thus, the inhibition of hepatic SphK1/S1P signaling pathway may be a novel mechanism by which morin exerts hepatoprotection in high fructose-fed rats, possibly involving liver inflammation inhibition and lipid accumulation recovery.
authors.affiliation: State Key Laboratory of Pharmaceutical Biotechnology, School of Life Science, Nanjing University, Nanjing, People's Republic of China.
authors.forename: Xing
authors.initials: X
authors.lastname: Wang
authors.forename: Dong-Mei
authors.initials: DM
authors.lastname: Zhang
authors.forename: Ting-Ting
authors.initials: TT
authors.lastname: Gu
authors.forename: Xiao-Qin
authors.initials: XQ
authors.lastname: Ding
authors.forename: Chen-Yu
authors.initials: CY
authors.lastname: Fan
authors.forename: Qin
authors.initials: Q
authors.lastname: Zhu
authors.forename: Yun-Wei
authors.initials: YW
authors.lastname: Shi
authors.forename: Ye
authors.initials: Y
authors.lastname: Hong
authors.forename: Ling-Dong
authors.initials: LD
authors.lastname: Kong
mesh_terms: D000818:Animals; D004040:Dietary Carbohydrates / Q000008:administration & dosage*; D005419:Flavonoids / Q000494:pharmacology*; D005632:Fructose / Q000008:administration & dosage*; D007249:Inflammation / Q000378:metabolism / Q000517:prevention & control*; D050356:Lipid Metabolism / Q000187:drug effects*; D008099:Liver / Q000187:drug effects*; D008246:Lysophospholipids / Q000378:metabolism*; D008297:Male; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D015398:Signal Transduction / Q000187:drug effects*; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000378:metabolism; D000099157:Sphingosine Kinase; D047309:Flavones
chemical_list: D004040:Dietary Carbohydrates; D005419:Flavonoids; D005632:Fructose; D008246:Lysophospholipids; D017853:Phosphotransferases (Alcohol Group Acceptor); D013110:Sphingosine; D000099157:Sphingosine Kinase; C060506:sphingosine 1-phosphate; C008548:morin; D047309:Flavones
keywords: Hepatic inflammation; Lipid accumulation; Morin; NF-κB; SphK1/S1P signaling pathway